Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Mouth Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

Biopsy 4Surgical Procedures, Operative 3Cisplatin 3Cetuximab 3Radiotherapy 2Fluorouracil 2Cyclophosphamide 2Celecoxib 2tozuleristide 1temsirolimus 1antineoplaston AS 2-1 1antineoplaston A10 1advexin 1Valproic Acid 1Thalidomide 1Sirolimus 1Observation 1Metformin 1Immunohistochemistry 1Immunoglobulin G 1Fluorescent Antibody Technique 1Flow Cytometry 1Fenretinide 1Everolimus 1Etoposide 1Electroacupuncture 1Docetaxel 1Disulfides 1Dihematoporphyrin Ether 1Diagnosis, Oral 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Mouth Neoplasms × 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a × Clear all
NCT00670397 2016-03-16

Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer

Roswell Park Cancer Institute

Phase 1 Terminated
11 enrolled
Head & Neck

Head and Neck Neoplasms, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡